## Abstract Insulinβlike growth factorβ1 (IGFβI), a potent mitogen, is hypothesized to influence breast cancer risk. In 3 previous studies, a polymorphism in the __IGFβ1__ gene (sequence repeat length) was associated with plasma IGFβI level. We evaluated prospectively the relationships among a (CA)
Insulin-Like Growth Factor-1 Inscribes a Gene Expression Profile for Angiogenic Factors and Cancer Progression in Breast Epithelial Cells
β Scribed by Oh, J.S.; Kucab, J.E.; Bushel, P.R.; Martin, K.; Bennett, L.; Collins, J.; DiAugustine, R.P.; Barrett, J.C.; Afshari, C.A.; Dunn, S.E.
- Book ID
- 122324098
- Publisher
- Neoplasia Press
- Year
- 2002
- Tongue
- English
- Weight
- 263 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1522-8002
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Tumor recurrence is a common problem in the treatment of breast cancer. In breast cancer, the expression of high protein levels of the insulin-like growth factor-1 receptor (IGF-1R) and urokinase-type plasminogen activator-1 (uPA) is strongly associated with breast cancer recurrence and decreased su
Mutations in the WTI tumor suppressor gene are known t o contribute t o the development of Wilms' tumor (WT) and associated gonadal abnormalities. WTI is expressed principally in the fetal kidney, developing gonads, and spleen and also in the mesothelium, which lines the coelomic cavities. These tis
## Abstract Human cathelicidin antimicrobial protein hCAP18/LLβ37 is an effector molecule of the nonspecific innate immune system. hCAP18/LLβ37 is present in leukocytes and is expressed in skin and other epithelia, where it is upregulated in association with inflammation and injury. In addition, an